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while genes associated with GPCR signaling were the major 
targets of HCV. Metabolic pathways were modulated by both HCV 
and HIV viruses.
Conclusions: This study for the first time offers gene profiling 
basis for HCV/HIV mono-/co- infections in human beings. HIV 
infection displayed the great impact on transcription profile of 
CD4+ T cells in HIV/HCV co-infected individuals. Genes related 
to cell cycle arrest were significantly mediated by HIV which may 
lead to dysfunction of CD4+ T cells and acceleration of HCV-
related disease progression in the co-infections.
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Background: Influenza infection begins with the attachment of 
the viral haemagglutinin (HA) to the surface receptor of a cell. This 
binding involves a glycan called sialic acid (Sia). Previous studies 
have suggested that the affinity of influenza viruses isolated 
from different species depends on the linkage between this Sia 
and the adjacent sugar (usually galactose). In general, human 
and swine viruses prefer  Sia with an α2-6 linkage while avian 
viruses prefer an α2-3 linkage. Though there are commercially 
available therapies that block influenza virus release, there has 
been limited information on controlling influenza virus infection by 
removing Sia from the host surface.
Objectives: The objectives of this study were firstly to identify 
the Sia present in the human respiratory tract and then see if 
these receptors were still present after sialidase treatment. We 
then investigated whether removal of this Sia by sialidase would 
reduce influenza infection in ex vivo tissues.
Methods: We used lectin histochemistry to identify the Siaα2-6 
and Siaα2-3 linkage and then re-examined this lectin binding after 
topical sialidase treatment. We then analyzed the tissues for the 
presence of sialylated glycans using mass spectrometry. Finally 
we tested the infection of human upper and lower respiratory tract 
tissues after sialidase treatment with avian and human viruses.
Results: We found that there was a diffuse expression of Siaα2-
6 throughout the upper and lower respiratory tract. Siaα2-3 
varied according to site with more N-linked Siaα2-3 glycans in 
the upper respiratory tract and more O-linked glycans in the 
lower respiratory tract. Sialidase treatment was able to remove 
both types of glycans. Unexpectedly we found that the effect of 
desialylation was not the same in all cell lines tested.
Conclusions: We found that both prophylactic as well as 
therapeutic sialidase treatment was able to prevent infection with 
avian and human influenza viruses and that the ex vivo model was 
a useful study tool for testing the efficicacy of novel therapeutic 
agents.
 
Implications: Sialidase therapy offers a potentially useful clinical 
option and this has now being used in a Phase II clinical trial for 
influenza and another sialic-acid receptor based infection caused 
by parainfluenza viruses.
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Background: Vaccination is generally considered to be the best 
primary prevention measure against influenza virus infection. 
Many countries encourage specific target groups of people to 
undertake vaccination, often with financial subsidies or a priority 
list. To understand differential patterns of national target groups 
for influenza vaccination before, during and after the 2009 
influenza pandemic, we reviewed and analyzed the country-
specific policies in the corresponding time periods.
Methods: Information on prioritized groups targeted to receive 
seasonal and pandemic influenza vaccines was derived from a 
multi-step internet search of official health department websites, 
press releases, media sources and academic journal articles. 
We assessed the frequency and consistency of targeting 20 
different groups within populations which are associated with 
age, underlying medical conditions, role or occupations among 
different countries and vaccines. Information on subsidies 
provided to specific target groups was also extracted.
Results: We analyzed target groups for 33 (seasonal 2009 and 
2009-10 vaccines), 72 (monovalent pandemic 2009-10 vaccine) 
and 34 (seasonal 2010 and 2010-11 vaccines) countries. In 2009-
10, the elderly, those with chronic illness and health care workers 
were common targets for the seasonal vaccine. Comparatively, 
the elderly, care home residents and workers, animal contacts 
and close contacts were less frequently targeted to receive the 
pandemic vaccine. Pregnant women, obese persons, essential 
community workers and health care workers, however, were 
more commonly targeted. After the pandemic, pregnant women, 
obese persons, health care and care home workers, and close 
contacts were more commonly targeted to receive the seasonal 
vaccine compared to 2009-10, showing continued influence from 
the pandemic. Many of the countries provided free vaccines, 
partial subsidies, reimbursements or national health insurance 
coverage to specific target groups and over one-third of the 
countries offered universal subsidy regarding the pandemic 
vaccine. There was also some inconsistency between countries 
in target groups.
Conclusions: Differences in target groups between countries 
may reflect variable objectives as well as uncertainties 
regarding the transmission dynamics, severity and age-specific 
immunity against influenza viruses before and after vaccination. 
Clarification on these points is essential to elucidate optimal and 
object-oriented vaccination strategies.
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